Tuesday
07.23.2019
12:04 PM
Login form
Search
Calendar
«  December 2012  »
SuMoTuWeThFrSa
      1
2345678
9101112131415
16171819202122
23242526272829
3031
Entries archive

My site

Main » 2012 » December » 27
DUBLIN - Thursday, December 27th 2012 [ME NewsWire]

(BUSINESS WIRE)-- Covidien(NYSE: COV), a leading global provider of healthcare products, today announced a definitive agreement to acquire CV Ingenuity.The companies expect to complete the acquisition in the first calendar quarter of 2013. Financial terms of the transaction were not disclosed.

CV Ingenuity, a privately-held company based in Fremont, CA, is focused on improving patient outcomes in the treatment of peripheral arterial disease (PAD) by providing solutions to relieve vascular obstructions, inhibit restenosis, and allow natural vessel healing. The company's core technology, while still in the investigational phase, is a Drug Coated Balloon (DCB) platform with a novel, proprietary, tunable, rapid-release system.

"We continue to be focused on technologies that deliver improved patient care, delighting both our physician and hospital system customers,” said Stacy Enxing Seng, President, Vascular Therapies ... Read more »
Views: 118 | Added by: uaeonlinenews | Date: 12.27.2012